The COVID-19 pandemic has disrupted clinical operations and accelerated much-needed change, according to a new survey conducted by Informa Pharma Intelligence on behalf of Oracle Health Sciences. With patients unable to physically visit clinical trial sites, 76% of survey respondents noted that the pandemic sped their adoption of decentralized clinical trial methods. 
Bayer will support five new startup companies as part of the company's G4A Digital Health Partnerships Program. Focus will be on fostering the development of a digital health ecosystem, while driving forward integrated healthcare solutions in the fields of cardiometabolic and renal diseases, oncology, and women's health. The participating digital healthcare companies were selected by Bayer from over 400 applications from over 65 countries based upon current and future strategic fit, development stage and assessment. 
Leicester's Hospitals have taken another leap forward in their electronic patient record (EPR) journey by deploying a closed-loop mobile electronic prescribing and medicines administration (EPMA) system at Leicester General Hospital.
The EPR programme is a collaboration between clinical and technical teams at University Hospitals of Leicester NHS Trust and the Nervecentre software development team, to build a next generation, mobile first digital patient record system.
Industry veteran Jeremy Nettle reflects on a recent debate by the Highland Marketing advisory board on the role of national and local organisations in NHS IT policy, funding and implementation. Twenty-years of switching focus has created confusion and delay, he argues, and it's time for a new model. 
Visionable, the rapidly expanding British health technology company focused on health system redesign, is extending its Connected Ambulance offering after receiving a £500,000 Smart Grant from Innovate UK, the UK's innovation agency. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced leading pathology laboratories across North America, Europe, and Asia have implemented full digitization for their histology samples based on the Philips Digital Pathology scanner and imaging-informatics solutions. 
The COVID-19 High Performance Computing (HPC) Consortium, a unique public-private effort to make supercomputing power available to researchers working on projects related to COVID-19, announced that it has entered into a new phase of operation focused on helping researchers to identify potential near term therapies for patients afflicted by the virus.